Bilzen, Belgium

Ludwig Jerome Dubois

This inventor holds 1 USPTO granted patent. Top assignee: University of Maastricht. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ludwig Jerome Dubois. Retrieved from https://idiyas.com/inventor/ludwig-jerome-dubois

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Radiotherapy by Ludwig Jerome Dubois

Introduction

Ludwig Jerome Dubois is an accomplished inventor based in Bilzen, Belgium. He has made significant contributions to the field of radiotherapy, particularly in the treatment planning for lymphocyte-sparing radiotherapy. His innovative approach aims to enhance the effectiveness of radiation treatment while minimizing damage to healthy tissues.

Latest Patents

Dubois holds a patent for a method titled "Treatment and planning for lymphocytes sparing radiotherapy." This patent outlines a comprehensive process for creating a radiation treatment plan for neoplasms. The method involves obtaining images of the neoplasm, segmenting target volumes, and identifying organs-at-risk. Furthermore, it includes the segmentation of lymphocyte-rich organs and the development of a radiation dose regime that optimally targets the neoplasm while protecting healthy tissues.

Career Highlights

Ludwig Jerome Dubois is affiliated with Universiteit Maastricht, where he continues to advance research in radiotherapy. His work focuses on improving treatment outcomes for patients with neoplasms through innovative planning systems that prioritize the preservation of lymphocyte-rich organs.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Ludwig Jerome Dubois's contributions to radiotherapy exemplify the importance of innovation in medical treatment. His patent for lymphocyte-sparing radiotherapy represents a significant advancement in the field, aiming to improve patient outcomes while minimizing side effects.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…